Clinical trial
Quantifying Musical Performance After Treatment With Myobloc in Musician's…
NCT00208091 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00208091 |
|---|---|
| Title | Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia |
| Official title | An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®). |
| Lead sponsor | Columbia University, Other |
| Collaborators | Solstice Neurosciences Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Focal Dystonia |
| Intervention type | Drug |
| Interventions | Botulinum toxin, type B |
| Enrollment | 16 |
| Start date | Apr 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: